Overall survival data from EMBARK trial support enzalutamide plus leuprolide as standard of care. Medscape Medical News Source link : https://www.medscape.com/viewarticle/enzalutamide-extends-survival-high-risk-prostate-cancer-2025a1000sk5?src=rss Author : Publish date : 2025-10-21 14:48:00 Copyright for...
Read more













